MedTrace Logo

Brain Injury Biomarkers in the General Population

NCT01786460 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2017-01-31

No results posted yet for this study

Summary

The purpose of this study is to use an investigational assay to assess levels of putative biomarkers of traumatic brain injury (TBI) in a general population. The data will be used in a correlative analysis with data collected under a separate study of severe TBI.

Conditions

  • Brain Injuries, Traumatic

Interventions

OTHER

Blood draw at Days 0, 7, 14, and 21

Sponsors & Collaborators

  • Banyan Biomarkers, Inc

    lead INDUSTRY

Principal Investigators

  • Jackson Streeter, MD · Banyan Biomarkers

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01786460 on ClinicalTrials.gov